Literature DB >> 19456191

Comparison of carotid stents: an in-vitro experiment focusing on stent design.

Stefan Müller-Hülsbeck1, Philipp J Schäfer, Nikolas Charalambous, Silvio R Schaffner, Martin Heller, Thomas Jahnke.   

Abstract

PURPOSE: To examine and compare different carotid stent designs with regard to flexibility, adaptability (adjustability), conformability (compliance) to the vessel, and scaffolding to reduce plaque prolapse and embolization.
METHODS: Six stents of different design were compared (Precise, Acculink, Protégé, Xact, Wallstent, and Cristallo Ideale). Optical microscopy was used to determine exact dimensions and scaffolding of each stent. Radial force was tested using a parallel plate setup, and flexibility (torsion and bending) was measured in water at body temperature. Particle penetration simulation was performed using plastic spheres from 1.5- to 6.0-mm outer diameter.
RESULTS: Stent dimensions met the manufacturers' data; none of the products showed any failure during the test program. Cell sizes in the middle part of the stents ranged from 1.36 mm(2) (Wallstent) to 15.10 mm(2) (Acculink). Bending forces at 20 degrees /30 degrees ranged from 0.063 N / 0.074 N (Cristallo Ideale) to 0.890 N / 0.616 N (Xact); forces to achieve torsion at 10 degrees /15 degrees ranged from 0.032 N / 0.043 N (Acculink) to 0.905 N / 1.071 N (Xact). According to the parallel plate method, mean lowest force was measured for Xact (0.765 N), while the Wallstent had the highest force (2.136 N). Mean radial force measurements were lowest for Cristallo Ideale (9.06 N at mid part) and highest for Protégé (24.09 N). The Cristallo Ideale stent at mid part resisted penetration by all but the smallest plastic spheres (1.5-mm spheres penetrated only at 0.65 N); the Precise and Protégé stent had the highest variation in sphere penetration (1.5- to 4.0-mm spheres). Only the Acculink let 6-mm spheres penetrate.
CONCLUSION: Despite comparable stent sizes, these carotid stents showed differences in behavior due to stent design. The open-cell design displayed the greatest flexibility and adaptability to the vessel but easily allowed particle penetration due to the open structure. Closed-cell designs had low flexibility and thus low adaptability to the vessel but high resistance to particle penetration due to the closed-cell design and high scaffolding. The hybrid stent design (Cristallo Ideale) was able to combine both the flexibility of an open-cell structure and the resistance to particle penetration of closed-cell structures.

Entities:  

Mesh:

Year:  2009        PMID: 19456191     DOI: 10.1583/08-2539.1

Source DB:  PubMed          Journal:  J Endovasc Ther        ISSN: 1526-6028            Impact factor:   3.487


  16 in total

1.  Carotid endarterectomy versus stenting: Does the flow really change? An Echo-Color-Doppler analysis.

Authors:  Pierleone Lucatelli; Fabrizio Fanelli; Carlo Cirelli; Beatrice Sacconi; Michele Anzidei; Roberto Montisci; Roberto Sanfilippo; Elisabetta Tamponi; Carlo Catalano; Luca Saba
Journal:  Int J Cardiovasc Imaging       Date:  2015-02-20       Impact factor: 2.357

2.  CT angiography after carotid artery stenting: assessment of the utility of adaptive statistical iterative reconstruction and model-based iterative reconstruction.

Authors:  Keita Kuya; Yuki Shinohara; Makoto Sakamoto; Naoki Iwata; Junichi Kishimoto; Shinya Fujii; Toshio Kaminou; Takashi Watanabe; Toshihide Ogawa
Journal:  Neuroradiology       Date:  2014-08-13       Impact factor: 2.804

3.  Lesion-Related Carotid Angioplasty and Stenting with Closed-Cell Design without Embolic Protection Devices in High-Risk Elderly Patients-Can This Concept Work Out? A Single Center Experience Focusing on Stent Design.

Authors:  Silke Hopf-Jensen; Leonardo Marques; Michael Preiß; Stefan Müller-Hülsbeck
Journal:  Int J Angiol       Date:  2014-12

4.  Prediction of Prolonged Hemodynamic Instability During Carotid Angioplasty and Stenting.

Authors:  Jong Kook Rhim; Jin Pyeong Jeon; Jeong Jin Park; Hyuk Jai Choi; Young Dae Cho; Seung Hun Sheen; Kyung-Sool Jang
Journal:  Neurointervention       Date:  2016-09-03

5.  Stent recanalization of carotid tonsillar loop dissection using the Enterprise vascular reconstruction device.

Authors:  Jason P Rahal; Bulang Gao; Mina G Safain; Adel M Malek
Journal:  J Clin Neurosci       Date:  2013-12-08       Impact factor: 1.961

6.  An Efficient Finite Element Framework to Assess Flexibility Performances of SMA Self-Expandable Carotid Artery Stents.

Authors:  Mauro Ferraro; Ferdinando Auricchio; Elisa Boatti; Giulia Scalet; Michele Conti; Simone Morganti; Alessandro Reali
Journal:  J Funct Biomater       Date:  2015-07-14

7.  Carotid artery stenting without post-stenting balloon dilatation.

Authors:  Atsushi Ogata; Makoto Sonobe; Noriyuki Kato; Tomosato Yamazaki; Hiromichi Kasuya; Go Ikeda; Shunichiro Miki; Toshio Matsushima
Journal:  J Neurointerv Surg       Date:  2013-09-07       Impact factor: 5.836

8.  Clinical trial of carotid artery stenting using dual-layer CASPER stent for carotid endarterectomy in patients at high and normal risk in the Japanese population.

Authors:  Hirotoshi Imamura; Nobuyuki Sakai; Yasushi Matsumoto; Hiroshi Yamagami; Tomoaki Terada; Toshiyuki Fujinaka; Shinichi Yoshimura; Kenji Sugiu; Akira Ishii; Yuji Matsumaru; Takashi Izumi; Hidenori Oishi; Toshio Higashi; Koji Iihara; Naoya Kuwayama; Yasushi Ito; Masato Nakamura; Akio Hyodo; Kuniaki Ogasawara
Journal:  J Neurointerv Surg       Date:  2020-09-15       Impact factor: 5.836

9.  Percutaneous biliary drainage using open cell stents for malignant biliary hilar obstruction.

Authors:  Sun Jun Ahn; Jae Ik Bae; Tae Sun Han; Je Hwan Won; Ji Dae Kim; Kyu-Sung Kwack; Jae Hee Lee; Young Chul Kim
Journal:  Korean J Radiol       Date:  2012-10-12       Impact factor: 3.500

10.  The correlation between the cardiovascular instability and the size of the developed ischaemic lesions in patients who underwent carotid stenting.

Authors:  Sándor Csizmadia; Zsófia Kaszás; Róbert Klucsai; Éva Bartha; Erika Vörös
Journal:  Neuroradiol J       Date:  2021-01-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.